Petros Pharmaceuticals, Inc. (PTPI) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.14M | +198.9% |
| 2024 | $1.72M | -87.1% |
| 2023 | $13.34M | +41.5% |
| 2022 | $9.43M | -60.5% |
| 2021 | $23.85M | +39.1% |
| 2020 | $17.14M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.14M | +198.9% |
| 2024 | $1.72M | -87.1% |
| 2023 | $13.34M | +41.5% |
| 2022 | $9.43M | -60.5% |
| 2021 | $23.85M | +39.1% |
| 2020 | $17.14M | — |